Transplantation of bone marrow cells from nonobese diabetic (NOD) mice, a model for type 1 diabetes mellitus, to C3H/HeN mice, which express I-Ea molecules and have aspartic acid at residue 57 of the I-Ap chain, induced insulitis followed by overt diabetes in the recipient C3H/HeN mice more than 40 weeks after bone marrow transplantation. When cyclosporin A, which perturbs T-ceil functions, was injected intraperitoneally into [NOD -* C3H/HeN] chimeric mice daily for 1 month, the chimeric mice developed insulitis and overt diabetes within 20 weeks following bone marrow transplantation. Transplantation of bone marrow cells from (NZW x BXSB)F1 mice, which develop lupus nephritis, myocardial infarction, and idiopathic thrombocytopenic purpura, into C3H/HeN or C57BL/6J mice induced in the recipient strains both lupus nephritis and idiopathic thrombocytopenic purpura more than 3 months after transplantation.
mice daily for 1 month, the chimeric mice developed insulitis and overt diabetes within 20 weeks following bone marrow transplantation. Transplantation of bone marrow cells from (NZW x BXSB)F1 mice, which develop lupus nephritis, myocardial infarction, and idiopathic thrombocytopenic purpura, into C3H/HeN or C57BL/6J mice induced in the recipient strains both lupus nephritis and idiopathic thrombocytopenic purpura more than 3 months after transplantation. Transplantation of a stem-cell-enriched population from (NZW x BXSB)F, mice into normal mice also induced autoimmune disease in the recipients. These results indicate that both systemic autoimmune disease and organ-specific autoimmune disease originate from defects that reside within the stem cells; the thymus and environmental factors such as sex hormones appear to act only as accelerating factors.
Since the thymus plays a crucial role in positive and negative selection of T cells and is engaged in deletion of autoreactive clones (1) , it has been thought that the etiopathogenesis of both systemic and organ-specific autoimmune diseases could be attributed to defects in the thymus. However, considerable evidence indicates that autoimmune diseases originate from defects that reside in the hematopoietic stem cells (2) (3) (4) (5) (6) (7) . Previous studies (7-11) using autoimmune-prone mice demonstrated that allogeneic bone marrow transplantation (BMT) can be used to prevent and treat both systemic and organ-specific autoimmune diseases. In this context, we decided that it would be important to determine whether transplantation of particular bone marrow cells, especially hematopoietic stem cells from bone marrow of autoimmuneprone mice, would lead to the development of autoimmune diseases in normal mice, an environment that includes the normal thymus.
We 
MATERIAL AND METHODS
Mice. Nonobese diabetic (NOD) mice were obtained from Shionogi Aburahi Laboratories (Shiga, Japan) and maintained under specific pathogen-free conditions in the animal facility at Kansai Medical University. NZW and BXSB mice (The Jackson Laboratory) and (NZW x BXSB)F1 (W/BF1) mice were maintained under specific pathogen-free conditions at Kiwa Laboratory Animals (Wakayama, Japan). C57BL/6J and C3H/HeN mice were obtained from CLEA Japan (Osaka).
BMT. Mice were exposed to 9.5 Gy from a 'Co source and then reconstituted by intravenous injection of 1.0 x 107 T-cell-depleted bone marrow cells or 1.0 x 106 cells of a stem-cell-enriched population from young autoimmuneprone mice, as described (10) . Cytofluorometric Analyses. Analyses of H-2 determinants, platelet-associated antibodies, and circulating anti-platelet antibodies were carried out using a FACStar (Becton Dickinson), as described (11, 12) . Spleen cells suspended in phosphate-buffered saline containing 2% fetal bovine serum and 0.05% sodium azide were stained with fluorescein isothiocyanate-conjugated monoclonal antibodies against H-2Dd (030-20F), H-2Db (030-14F), H-2Kd (030-21F), or H-2Kb (030-llF). Monoclonal antibodies were purchased from the Meiji Institute of Health Science (Odawara, Japan).
Glucose Tolerance Tests. These were carried out as described (9) .
Preparation of a Stem-Cell-Enriched Population. To obtain a stem-cell-enriched population, bone marrow cells that had been depleted of T cells, B cells, and macrophages were fractionated by centrifugation in a Percoll discontinuous density gradient (13) .
Histological Study. Major organs were obtained at autopsy, and sections were stained with hematoxylin/eosin. For immunohistochemical studies, specimens were immediately embedded in optimal-cutting-temperature compound and frozen in dry ice/acetone. Two-micrometer cryostat sections were used for immunohistochemical study (9, 10) .
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The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact. mune disease, insulin-dependent diabetes mellitus, which occurs in NOD mice, could be transferred to normal mice by transplantation of NOD bone marrow cells. C3H/HeN mice were used as recipients. Mice of this strain express I-Ea molecules and have an aspartic acid at residue 57 (Asp-57) of the I-Ap chain (14, 15) . We selected this strain because it has been postulated that failure to express the Ea gene is the abnormality that permits NOD mice to develop insulitis, which leads to diabetes (16, 17) . Also, it is thought that replacement of Asp-57 with Ser (non-Asp) in NOD mice (18) and with non-Asp in humans (19) may be the molecular anomaly responsible for the development of insulindependent diabetes. Female C3H/HeN (H-2k) mice were lethally irradiated (9.5 Gy) at the age of 8 weeks and then reconstituted with T-cell-depleted bone marrow cells of young (<8 weeks) female NOD (Kd, I-ANOD, Db) mice. As controls, more than 50 C3H/HeN (H-2k) mice were lethally irradiated and then reconstituted with T-cell-depleted bone marrow cells of C3H/HeN, C57BL/6J (H-2b), or BALB/c (H-2d) mice. Even though these survived more than 1 year (survival rate, >90%), neither insulitis nor overt diabetes developed. However, two of four [NOD -+ C3H/HeN] chimeric mice developed both insulitis and overt diabetes 40 weeks after BMT (Fig. la) . These mice exhibited elevated glucose levels and abnormal glucose tolerance curves. CsA was found to accelerate the development of diabetes in such recipient mice, perhaps because CsA given to neonatal mice can inhibit and perturb T-cell functions and lead to the development of organ-specific autoimmune diseases (20) .
[NOD --C3H/HeN] mice were treated 1 month after BMT with CsA (10 mg/kg of body weight) daily for 1 month. Two of five mice in this group developed insulitis and overt diabetes as early as 20 weeks following BMT (Fig. lb) . In these two mice, the beta cells of the pancreas were specifically destroyed by lymphocytes that had infiltrated the pancreatic islets (Fig. 2) , indicating that the insulitis was not due to other influences of graft-versus-host reaction. Cytofluorometric analyses of spleen cells from [NOD -* C3H/HeN] mice revealed that hematolymphoid cells of the recipients had been replaced with donor (NOD)-derived cells (Fig. 3) . .0 E 0* 0 ,, ,,-,,.. .,n .,.. Cytofluorometric analyses demonstrated the presence of both platelet-associated antibodies and circulating antiplatelet antibodies in the thrombocytopenic mice (Fig. 4) . Analyses were carried out as described (11, 12) . autoreactive clones (1, (22) (23) (24) (25) , it is the stem cells (upon which the thymus acts) that contain the abnormalities that culminate in the expression of either organ-specific autoimmunities directed toward specific hematological cells or systemic autoimmune injuries resulting from immune complexmediated autoimmunities. In addition, these findings suggest that genetically based susceptibility to most classes of autoimmune diseases, at least in mice, reside within the hematopoietic stem cells.
